THE RISK OF OSTEONECROSIS OF THE JAW IN TAIWANESE OSTEOPOROTIC PATIENTS TREATED WITH ORAL ALENDRONATE OR RALOXIFENE

被引：0
|
作者：
Chiu, W. -Y. [1 ]
Chien, J. -Y. [2 ]
Yang, W. -S. [3 ]
Juang, J. -M J. [2 ]
Lee, J. -J. [4 ]
Tsai, K. -S. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P695
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [41] Suspected bisphosphate-related osteonecrosis of the jaw in a cat being treated with alendronate for idiopathic hypercalcaemia
    Rogers-Smith, Emma
    Whitley, Nat
    Elwood, Clive
    Reese, David
    Wong, Paula
    VETERINARY RECORD CASE REPORTS, 2019, 7 (03):
  • [42] Jaw osteonecrosis in patients treated with bisphosphonates: MDCT evaluation
    Milillo, P.
    Garribba, A. P.
    Favia, G.
    Ettorre, G. C.
    RADIOLOGIA MEDICA, 2007, 112 (04): : 603 - 611
  • [43] Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Hoff, Ana O.
    Toth, Bela B.
    Altundag, Kadri
    Johnson, Marcella M.
    Warneke, Carla L.
    Hu, Mimi
    Nooka, Ajay
    Sayegh, Gilbert
    Guarneri, Valentina
    Desrouleaux, Kimberly
    Cui, Jeffrey
    Adamus, Andrea
    Gagel, Robert F.
    Hortobagyi, Gabriel N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (06) : 826 - 836
  • [44] Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico
    Veronica Cuevas-Gonzalez, Maria
    Minerva Diaz-Aguirre, Celia
    Echevarria-y-Perez, Enrique
    Carlos Cuevas-Gonzalez, Juan
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2016, 42 (06) : 365 - 369
  • [45] Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
    P. A. Eiken
    D. Prieto-Alhambra
    R. Eastell
    B. Abrahamsen
    Osteoporosis International, 2017, 28 : 2921 - 2928
  • [46] Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
    Eiken, P. A.
    Prieto-Alhambra, D.
    Eastell, R.
    Abrahamsen, B.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 2921 - 2928
  • [47] Incidence of adverse effects in osteoporotic patients treated with alendronate.
    Zanchetta, JR
    Spivacow, R
    Rey, P
    Morillo, S
    Insua, A
    Rodriguez, G
    Negri, A
    DelValle, E
    Massari, F
    Sarli, M
    Talbot, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S465 - S465
  • [48] COMMENT ON: MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROTIC PATIENTS: PREVENTION AND MANAGEMENT
    Toh, Choon Lai
    Dutton, Andrew
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (05) : 287 - 287
  • [49] COMMENT ON: MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROTIC PATIENTS: PREVENTION AND MANAGEMENT
    Ngeow, Wei Cheong
    Chai, Wen Lin
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (01) : 52 - 52
  • [50] Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures
    F. Lapi
    F. Cipriani
    A. P. Caputi
    G. Corrao
    A. Vaccheri
    M. C. Sturkenboom
    M. Di Bari
    D. Gregori
    F. Carle
    T. Staniscia
    A. Vestri
    M. Brandi
    V. Fusco
    G. Campisi
    G. Mazzaglia
    Osteoporosis International, 2013, 24 : 697 - 705
12345